Sign Out
Each film-coated tablet contains: Trimetazidine (as diHCl) BP 35 mg (in modified release form).
Trimetazidine is a metabolic agent, a specific and selective inhibitor of enzymes of the fatty acids β-oxidation: The 3 ketoacyl CoA thiolase (3-KAT). This inhibition of β-oxidant allows a recoupling of glycolysis and an increase in glucose oxidation for better energy production under ischemic conditions.
